Gaudium Ivf Ipo
Gaudium IVF IPO Review & Key Points
Review: Neutral
Peer Group Comparison
There are no listed industry peers available.
IPO Lead Managers aka Merchant Bankers
Sarthi Capital Advisors Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 189 | ₹14,931 |
| Retail Maximum | 13 | 2,457 | ₹1,94,103 |
| S-HNI Minimum | 14 | 2,646 | ₹2,09,034 |
| S-HNI Maximum | 66 | 12,474 | ₹9,85,446 |
| B-HNI Minimum | 67 | 12,663 | ₹10,00,377 |
| Investor Category | Share Offered | Shares (%) |
| Anchor Investor | 62,65,860 Shares | 30% |
| QIB (Ex. Anchor) | 41,77,240 Shares | 20% |
| NII Shares Offered | 31,32,930 Shares | 15% |
| Retail Shares Offered | 73,10,170 Shares | 35% |
| Anchor Bidding Date | February 19, 2026 |
| Anchor Investors List | |
| Shares Offered | 62,65,860 Shares |
| Anchor Size | 49.50 Cr. |
| lock-in period end date 50% shares (30 Days) | March 27, 2026 |
| lock-in period end date 50% shares (90 Days) | May 26, 2026 |
| IPO Open Date: | February 20, 2026 |
| IPO Close Date: | February 24, 2026 |
| Basis of Allotment: | February 25, 2026 |
| Refunds: | February 26, 2026 |
| Credit to Demat Account: | February 26, 2026 |
| IPO Listing Date: | February 27, 2026 |
| IPO Bidding Cut-off Time: | February 24, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 6,13,94,384 | 99.99% |
| Promoter Holding Post Issue | 7,27,86,884 | 71.30% |
| Purpose | Crores |
| Funding capital expenditure towards establishment of New IVF Centers of the Company | ₹50 |
| Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and | ₹20 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹44.26 | ₹25.95 | ₹13.53 | ₹36.63 |
| 2024 | ₹48.15 | ₹31.52 | ₹10.32 | ₹51.01 |
| 2025 | ₹70.96 | ₹45.54 | ₹19.13 | ₹88.51 |
| Sep 2025 | ₹49.75 | ₹32.97 | ₹12.51 | ₹106.62 |
| KPI | Values |
| ROE: | 41.31% |
| ROCE: | 39.70% |
| EBITDA Margin: | 40.48% |
| PAT Margin: | 26.96% |
| Debt to equity ratio: | 0.41 |
| Earning Per Share (EPS): | ₹3.12 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 41.71% |
| Net Asset Value (NAV): | ₹7.54 |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| IPO Open Date | February 20, 2026 |
| IPO Close Date | February 24, 2026 |
| Face Value | ₹5 Per Equity Share |
| IPO Price Band | ₹75 to ₹79 Per Share |
| Issue Size | Approx ₹165 Crores |
| Fresh Issue | Approx ₹90 Crores |
| Offer for Sale: | Approx 94,93,700 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |